HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gwynn Long Selected Research
Gwynn Long Research Topics
Disease
6
Multiple Myeloma
02/2023 - 02/2015
3
Neoplasms (Cancer)
01/2021 - 05/2008
2
Frailty
01/2022 - 01/2021
2
Graft vs Host Disease (Graft-Versus-Host Disease)
08/2010 - 05/2008
1
Cognitive Dysfunction
01/2022
1
Hematologic Neoplasms (Hematological Malignancy)
01/2021
1
Inflammation (Inflammations)
01/2021
1
Delirium
12/2020
1
Systemic Scleroderma (Systemic Sclerosis)
03/2011
1
Infections
08/2010
1
Sickle Cell Anemia (Hemoglobin S Disease)
12/2007
1
Renal Insufficiency (Renal Failure)
12/2007
1
Chronic Kidney Failure (Chronic Renal Failure)
12/2007
Drug/Important Bio-Agent (IBA)
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
05/2017 - 03/2011
2
fludarabine
IBA
05/2008 - 12/2007
1
sphingosine kinase
IBA
02/2023
1
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
01/2021
1
pasireotide
IBA
01/2021
1
beta-Defensins
IBA
01/2021
1
Dexamethasone (Maxidex)
FDA Link
Generic
05/2017
1
Bortezomib (Velcade)
FDA Link
05/2017
1
Clostridium perfringens epsilon-toxin
IBA
02/2015
1
Tacrolimus (Prograf)
FDA Link
Generic
05/2008
1
Busulfan (Busulfex)
FDA Link
05/2008
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
05/2008
Therapy/Procedure
4
Hematopoietic Stem Cell Transplantation
01/2022 - 02/2015
4
Transplantation
01/2021 - 05/2008
4
Drug Therapy (Chemotherapy)
12/2017 - 02/2015
4
Stem Cell Transplantation
12/2017 - 12/2007
2
Therapeutics
01/2021 - 02/2015
1
Length of Stay
01/2022
1
Hematopoietic Stem Cell Mobilization
06/2015
1
Blood Component Removal (Apheresis)
02/2015